Results 31 to 40 of about 71,442 (257)
Escherichia coli and Sudden Infant Death Syndrome
Frontiers in Immunology, 2015 This review examines the association of strains of Escherichia coli with Sudden Infant Death Syndrome (SIDS) and the possible role of these bacteria play in this enigmatic condition. The review addresses evidence for E.
Paul Nathan Goldwater +1 more
doaj +1 more source
Children, 2021 Duchenne muscular dystrophy is a progressive and lethal X-linked recessive neuromuscular disease caused by mutations in the dystrophin gene. It has a high rate of diagnostic delay; early diagnosis and treatment are often not possible due to delayed ...
Eun-Woo Park +5 more
doaj +1 more source
JAMA Neurology, 2020 Key Points Question What are the safety, tolerability, and efficacy of viltolarsen in boys with Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping?
P. Clemens +12 more
semanticscholar +1 more source
Cahiers du MIMMOC, 2012 Cet article revisite deux grands titres de la presse quotidienne belge, à savoir De Standaard et Le Soir, pour découvrir les perceptions qui entourèrent les événements qui se sont succédés entre l’été 1989 et l’automne 1990.
Geneviève Duchenne
doaj +1 more source
Eteplirsen in the treatment of Duchenne muscular dystrophy
Drug Design, Development and Therapy, 2017 Duchenne muscular dystrophy is a fatal neuromuscular disorder affecting around one in 3,500–5,000 male births that is characterized by progressive muscular deterioration.
K. Lim, R. Maruyama, T. Yokota
semanticscholar +1 more source
Gene Therapy for Duchenne Muscular Dystrophy
Journal of Neuromuscular Diseases, 2021 Duchenne muscular dystrophy (DMD) is an X-linked, muscle wasting disease that affects 1 in 5000 males. Affected individuals become wheelchair bound by the age of twelve and eventually die in their third decade due to respiratory and cardiac complications.
Nertiyan Elangkovan, George Dickson
semanticscholar +1 more source
International Journal of Neonatal Screening, 2018 Duchenne muscular dystrophy (DMD/Duchenne) is one of the ten most severe and common pediatric genetic diseases and affects an estimated 1 in every 5000 male births.
Michele A. Lloyd-Puryear +9 more
doaj +1 more source
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
Genes, 2020 Neuromuscular disorders encompass a heterogeneous group of conditions that impair the function of muscles, motor neurons, peripheral nerves, and neuromuscular junctions.
Chengmei Sun +3 more
semanticscholar +1 more source
Science Advances, 2020 Self-complementary AAV-packaged CRISPR-Cas9 genome editing components rescue Duchenne muscular dystrophy. Duchenne muscular dystrophy (DMD) is a lethal neuromuscular disease caused by mutations in the dystrophin gene (DMD).
Yu Zhang +10 more
semanticscholar +1 more source
Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study. [PDF]
PLoS ONE, 2016 Altered neuronal nitric oxide synthase function in Duchenne muscular dystrophy leads to impaired mitochondrial function which is thought to be one cause of muscle damage in this disease.
Patricia Hafner +16 more
doaj +1 more source